The Antifibrotic Effect of A<sub>2B</sub> Adenosine Receptor Antagonism in a Mouse Model of Dermal Fibrosis
Harry Karmouty‐Quintana(The University of Texas Health Science Center), Tingting Weng(Fujian Medical University), Jose G. Molina(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Brent Gudenkauf(Johns Hopkins University), Shervin Assassi(University of Houston), Junsuk Ko(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Chiara Bellocchi(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Sandeep K. Agarwal(Baylor College of Medicine), Kemly Philip(The University of Texas Health Science Center), Michael R. Blackburn(Arkansas Children's Nutrition Center), Ning‐Yuan Chen(Yale University), Hongyan Zhong(Gilead Sciences (United States)), Minghua Wu(Central South University), Scott D. Collum(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico)
Cited by 21
Related Papers
Muc5b is required for airway defence
|Nature|2013|777
Cadherin-11 in Synovial Lining Formation and Pathology in Arthritis
|Science|2007|412
Future Directions in Idiopathic Pulmonary Fibrosis Research. An NHLBI Workshop Report
|American Journal of Respiratory and Critical Care Medicine|2013|247
Rosiglitazone Abrogates Bleomycin-Induced Scleroderma and Blocks Profibrotic Responses Through Peroxisome Proliferator-Activated Receptor-γ
|American Journal Of Pathology|2009|227